Renovaro (RENB) News Today $0.31 -0.01 (-1.59%) Closing price 04:00 PM EasternExtended Trading$0.32 +0.01 (+1.94%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RENB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Renovaro Inc. Secures Ruling to Expedite Trial Against Predictive Oncology Over Breach of Merger AgreementMay 24, 2025 | nasdaq.comRenovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology MergerMay 22, 2025 | insidermonkey.comUPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive OncologyMay 22, 2025 | globenewswire.comRenovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive OncologyMay 22, 2025 | globenewswire.comRenovaro partners with Amsterdam UMC on cancer diagnosticsMay 15, 2025 | uk.investing.comRenovaro lanceert AI-platform voor versnelling neurologische medicijnontwikkelingMay 15, 2025 | nl.investing.comRenovaro Inc. and Amsterdam UMC Enter Exclusive Collaboration to Develop Blood Platelet RNA DiagnosticsMay 15, 2025 | nasdaq.comRenovaro launches AI platform to advance neurology drug discoveryMay 15, 2025 | investing.comRenovaro Launches Augusta, an AI-Powered Precision Neurology PlatformMay 14, 2025 | globenewswire.comRenovaro gaat samenwerking aan met Amsterdam UMC voor kankerdiagnostiekMay 13, 2025 | nl.investing.comRenovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA DiagnosticsMay 13, 2025 | globenewswire.comRenovaro Inc. (NASDAQ:RENB) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC lifted its stake in shares of Renovaro Inc. (NASDAQ:RENB - Free Report) by 48.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,332,634 shares of the company's stock after buying an additional 76May 2, 2025 | marketbeat.comRENB-aandeel raakt 52-weeks dieptepunt van $ 0,32 door marktuitdagingenMay 1, 2025 | nl.investing.comRenovaro BioSciences expands collaboration with NebulApril 23, 2025 | markets.businessinsider.comRenovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic ProgramsApril 22, 2025 | globenewswire.comRenovaro riskeert Nasdaq-notering te verliezen door te lage aandelenkoersApril 18, 2025 | nl.investing.comRenovaro BioSciences, BioSymetrics close merger transactionApril 9, 2025 | markets.businessinsider.comRenovaro Inc: Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision MedicineApril 9, 2025 | finanznachrichten.deRenovaro fuseert met BioSymetrics voor AI-gedreven medicijnontwikkelingApril 9, 2025 | nl.investing.comRenovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision MedicineApril 9, 2025 | globenewswire.comPredictive Oncology Ends Merger Talks with RenovaroApril 7, 2025 | tipranks.comRenovaro Biosciences stuit op tegenslag bij fusie met Predictive OncologyApril 6, 2025 | nl.investing.comRenovaro Inc: Renovaro Provides Update to Definitive Agreement with Predictive OncologyApril 4, 2025 | finanznachrichten.deRenovaro BioSciences provides update to agreement with Predictive OncologyApril 4, 2025 | markets.businessinsider.comRenovaro Shares Fall After Merger SetbackApril 4, 2025 | marketwatch.comRenovaro says Predictive Oncology terminates merger transactionApril 4, 2025 | markets.businessinsider.comRenovaro Provides Update to Definitive Agreement with Predictive OncologyApril 4, 2025 | globenewswire.comRenovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive OncologyMarch 5, 2025 | nasdaq.comRenovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments?March 4, 2025 | insidermonkey.comRenovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreementMarch 3, 2025 | bizjournals.comRenovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive OncologyMarch 3, 2025 | globenewswire.comRenovaro Biosciences Buys AI-Driven BioSymetricsFebruary 27, 2025 | marketwatch.comRenovaro Inc. (RENB) Merges with BioSymetrics to Advance AI-Driven Cancer ResearchFebruary 27, 2025 | msn.comRenovaro Inc: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision MedicineFebruary 27, 2025 | finanznachrichten.deRenovaro BioSciences announces $15M in equity committedFebruary 27, 2025 | markets.businessinsider.comRenovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision MedicineFebruary 26, 2025 | globenewswire.comRenovaro Announces $15 million in Equity CommittedFebruary 26, 2025 | globenewswire.comRenovaro (NASDAQ:RENB) Posts Earnings ResultsRenovaro (NASDAQ:RENB - Get Free Report) released its earnings results on Wednesday. The company reported ($0.02) earnings per share (EPS) for the quarter.February 20, 2025 | marketbeat.comShort Interest in Renovaro Inc. (NASDAQ:RENB) Rises By 30.7%Renovaro Inc. (NASDAQ:RENB - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 5,060,000 shares, an increase of 30.7% from the December 15th total of 3,870,000 shares. Based on an average trading volume of 1,030,000 shares, the short-interest ratio is currently 4.9 days. Currently, 6.6% of the shares of the stock are sold short.January 18, 2025 | marketbeat.comRenovaro BioSciences appoints Fuentes as Chief Financial OfficerJanuary 7, 2025 | markets.businessinsider.comRenovaro BioSciences issues shareholder letter, provides corporate updateJanuary 7, 2025 | markets.businessinsider.comPREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAIJanuary 7, 2025 | businesswire.comRenovaro Biosciences Merges with Predictive OncologyJanuary 7, 2025 | tipranks.comRenovaro Inc. Appoints Nathen Fuentes As CFOJanuary 7, 2025 | markets.businessinsider.comRenovaro Inc: Renovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | finanznachrichten.deRenovaro Taps Nathen Fuentes as Finance ChiefJanuary 7, 2025 | marketwatch.comPredictive Oncology to be acquired by RenovaroJanuary 7, 2025 | markets.businessinsider.comRenovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | finance.yahoo.comRenovaro Issues Shareholder Letter and Provides Corporate UpdateJanuary 7, 2025 | globenewswire.comRenovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | globenewswire.com Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address RENB Media Mentions By Week RENB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENB News Sentiment▼1.260.87▲Average Medical News Sentiment RENB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENB Articles This Week▼21▲RENB Articles Average Week Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Design Therapeutics News enGene News Kodiak Sciences News Tonix Pharmaceuticals News Cardiff Oncology News SOPHiA GENETICS News Voyager Therapeutics News Y-mAbs Therapeutics News CARGO Therapeutics News ADC Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RENB) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovaro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Renovaro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RENB Stock Free RENB Stock Alerts